Rare diseases
Investigational molecules
Locations
Back to Greece685 clinical trials in Thessaloniki, Greece across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
GreeceStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
GreeceStudy of Isatuximab, Pomalidomide and Dexamethasone combination for multiple myeloma patients who previously received Lenalidomide and Proteasome Inhibitor therapy
GreeceStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
GreeceStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
GreeceStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
GreeceSafety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
GreeceStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
GreeceStudy on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia
GreeceStudy on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly
GreeceGreeceStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, multiple myeloma, and advanced malignancies. Research includes innovative treatments for bladder cancer and gastrointestinal tumors.
Investigations emphasize improving survival outcomes and treatment efficacy.
Clinical trials addressing various autoimmune disorders including cutaneous lupus erythematosus, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new biologics and targeted therapies.
Research focuses on developing more effective treatments with improved safety profiles.
Comprehensive studies on Type 1 Diabetes and obesity, investigating novel therapeutic approaches. Trials examine treatments for weight management and glycemic control.
Research aims to improve patient outcomes through innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
